Extracorporeal photopheresis for the treatment of steroid-refractory immune related adverse events from immune checkpoint inhibitor therapy: a multi-center phase Ib/II clinical trial

Roxane Riemer, Lukas M. Braun, Sophie Giesler, David Rafei-Shamsabadi, Sebastian Haferkamp, Alina Hartmann, Wolfgang Melchinger, Matthias Weiss, Stefanie Birth, Ulrike Philipp, Inga Gebhard, Carsten Schwänen, James A. Hutchinson, Nikolaos Karantzelis, Till Wallrabenstein, Theresa Lowinus, Niklas Brehm, Justyna Rawluk, Dietmar Pfeifer, Natascha Osswald, Peter Bronsert, Manuel Rogg, Grigor Andreev, Melanie Boerries, Maximilian Lammer, Van Anh Nguyen, Matthias Schmuth, Natalie Köhler, Justus Duyster, Gabriele Ihorst, Philip Keye, Susana Minguet, Dirk Schadendorf, Selma Ugurel, Robert Thimme, Peter Hasselblatt, Erika L. Pearce, Burkhard Becher, Carolin Funke-Lorenz, Florian Scherer, Bertram Bengsch, Christoph Schell, Jan-Malte Placke, Frank Meiss, Petya Apostolova, Robert Zeiser

Open source

DOI: 10.1038/s41467-026-78897-9
Published: 2026-10-23
Container: Nature Communications
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41467-026-78897-9,
  title = {Extracorporeal photopheresis for the treatment of steroid-refractory immune related adverse events from immune checkpoint inhibitor therapy: a multi-center phase Ib/II clinical trial},
  author = {Roxane Riemer and Lukas M. Braun and Sophie Giesler and David Rafei-Shamsabadi and Sebastian Haferkamp and Alina Hartmann and Wolfgang Melchinger and Matthias Weiss and Stefanie Birth and Ulrike Philipp and Inga Gebhard and Carsten Schwänen and James A. Hutchinson and Nikolaos Karantzelis and Till Wallrabenstein and Theresa Lowinus and Niklas Brehm and Justyna Rawluk and Dietmar Pfeifer and Natascha Osswald and Peter Bronsert and Manuel Rogg and Grigor Andreev and Melanie Boerries and Maximilian Lammer and Van Anh Nguyen and Matthias Schmuth and Natalie Köhler and Justus Duyster and Gabriele Ihorst and Philip Keye and Susana Minguet and Dirk Schadendorf and Selma Ugurel and Robert Thimme and Peter Hasselblatt and Erika L. Pearce and Burkhard Becher and Carolin Funke-Lorenz and Florian Scherer and Bertram Bengsch and Christoph Schell and Jan-Malte Placke and Frank Meiss and Petya Apostolova and Robert Zeiser},
  year = {2026},
  journal = {Nature Communications},
  doi = {10.1038/s41467-026-78897-9},
  url = {https://doi.org/10.1038/s41467-026-78897-9}
}

RIS

TY  - JOUR
TI  - Extracorporeal photopheresis for the treatment of steroid-refractory immune related adverse events from immune checkpoint inhibitor therapy: a multi-center phase Ib/II clinical trial
AU  - Roxane Riemer
AU  - Lukas M. Braun
AU  - Sophie Giesler
AU  - David Rafei-Shamsabadi
AU  - Sebastian Haferkamp
AU  - Alina Hartmann
AU  - Wolfgang Melchinger
AU  - Matthias Weiss
AU  - Stefanie Birth
AU  - Ulrike Philipp
AU  - Inga Gebhard
AU  - Carsten Schwänen
AU  - James A. Hutchinson
AU  - Nikolaos Karantzelis
AU  - Till Wallrabenstein
AU  - Theresa Lowinus
AU  - Niklas Brehm
AU  - Justyna Rawluk
AU  - Dietmar Pfeifer
AU  - Natascha Osswald
AU  - Peter Bronsert
AU  - Manuel Rogg
AU  - Grigor Andreev
AU  - Melanie Boerries
AU  - Maximilian Lammer
AU  - Van Anh Nguyen
AU  - Matthias Schmuth
AU  - Natalie Köhler
AU  - Justus Duyster
AU  - Gabriele Ihorst
AU  - Philip Keye
AU  - Susana Minguet
AU  - Dirk Schadendorf
AU  - Selma Ugurel
AU  - Robert Thimme
AU  - Peter Hasselblatt
AU  - Erika L. Pearce
AU  - Burkhard Becher
AU  - Carolin Funke-Lorenz
AU  - Florian Scherer
AU  - Bertram Bengsch
AU  - Christoph Schell
AU  - Jan-Malte Placke
AU  - Frank Meiss
AU  - Petya Apostolova
AU  - Robert Zeiser
PY  - 2026
JO  - Nature Communications
DO  - 10.1038/s41467-026-78897-9
UR  - https://doi.org/10.1038/s41467-026-78897-9
ER  -

APA

Riemer, R., Braun, L. M., Giesler, S., Rafei-Shamsabadi, D., Haferkamp, S., Hartmann, A., Melchinger, W., Weiss, M., Birth, S., Philipp, U., Gebhard, I., Schwänen, C., Hutchinson, J. A., Karantzelis, N., Wallrabenstein, T., Lowinus, T., Brehm, N., Rawluk, J., Pfeifer, D., Osswald, N., Bronsert, P., Rogg, M., Andreev, G., Boerries, M., Lammer, M., Nguyen, V. A., Schmuth, M., Köhler, N., Duyster, J., Ihorst, G., Keye, P., Minguet, S., Schadendorf, D., Ugurel, S., Thimme, R., Hasselblatt, P., Pearce, E. L., Becher, B., Funke-Lorenz, C., Scherer, F., Bengsch, B., Schell, C., Placke, J., Meiss, F., Apostolova, P., & Zeiser, R. (2026). Extracorporeal photopheresis for the treatment of steroid-refractory immune related adverse events from immune checkpoint inhibitor therapy: a multi-center phase Ib/II clinical trial. Nature Communications. https://doi.org/10.1038/s41467-026-78897-9

Source records

crossref · retrieved 2026-11-10T13:52:20.327Z